The increasing complexity of oncology treatment necessitates a thorough understanding of varied healthcare models. This article aims to explore the benefits website and weaknesses of transatlantic cancer care, evaluating the treatment protocols in both the United States and the European Union. Through a systemic lens, we will examine key variables,